IRCT20200623047902N7尚未招募未知
Bioequivalence study of Pantoprazole 40 mg tablet manufactured by Sanamed company versus the originator brand in fed and fast condition in healthy volunteers
Sanamed pharma company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (liver, heart, and kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to pantoprazole
研究者
相似试验
尚未招募
Unknown
Bioequivalence study of Pantoprazole 40 mg tabletThis study is performed on healthy volunteers..IRCT20200623047902N33Ronak Pharm company24
招募中
Unknown
Investigating bioequivalence of Pentoprazole capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N14Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of tablets of Esomeprazole 40 mgIRCT20230222057495N17Koushan Pharmed Pharmaceutical Company24
已完成
不适用
Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting StudyHealthyNCT01654705Ranbaxy Laboratories Limited80
已完成
不适用
Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed StudyHealthyNCT01654718Ranbaxy Laboratories Limited40